Tacita Capital Inc Bristol Myers Squibb CO Transaction History

Tacita Capital Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$57.89 - $64.73 $60,205 - $67,319	1,040 Added 717.24%	1,185 $68,000
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $25,484 - $28,295	-400 Reduced 73.39%	145 $9,000
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $5,585 - $6,335	-85 Reduced 13.49%	545 $38,000
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $4,720 - $5,198	-65 Reduced 9.35%	630 $49,000
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $18,136 - $21,747	295 Added 73.75%	695 $51,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $148,340 - $172,930	-2,766 Reduced 87.37%	400 $25,000
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $59,743 - $65,060	-965 Reduced 23.36%	3,166 $212,000
Q1 2021 May 14, 2021	SELL	$59.34 - $66.74 $1,958 - $2,202	-33 Reduced 0.79%	4,131 $261,000
Q4 2020 Feb 17, 2021	BUY	$57.74 - $65.43 $240,429 - $272,450	4,164 New	4,164 $258,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Tacita Capital Inc, based on Form 13F filings with the SEC.

Stay updated on Tacita Capital Inc with notifications on news.